Zoeken | FRIS onderzoeksportaal

Gekozen filters:

radiotherapy

Gekozen filters:

radiotherapy

1 - 10 of 4704 resultaten

Sorteren op

Health-related quality of life in breast cancer patients prior to and 3 years following adjuvant radiotherapy: Comparison between conventional and short-course, image-guided radiotherapy Vrije Universiteit Brussel

Hilde Van Parijs, Guy Storme, Harijati Versmessen, Geertje Miedema

Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspective Universiteit Antwerpen Universiteit Gent

Vincenzo Valentini, Yolande Lievens

Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy: A Systematic Review and Meta-Analysis KU Leuven

Dirk De Ruysscher

Stereotactic ablative body radiotherapy (SABR) is popular because of the high rates of local control with low toxicity seen in lung cancer patients. In this study we compared clinically significant toxicity and overall survival for SABR and non-SABR definitive radiotherapy (conformal radiotherapy) patients. A PUBMED search of all human, English language articles on SABR and non-SABR radically treated early stage lung cancer patients was ...

Radiotherapy prioritization in 143 national cancer control plans : correlation with radiotherapy machine availability, geography and income level Universiteit Gent

BE Wilson, A Oar, D Rodin, F Bray, J Ferlay, A Polo, JM Borras, JM Bourque, M Malik, F Ynoe de Moraes, et al.

Background: In 2015, the Global Task Force on Radiotherapy for Cancer Control (GTFRCC) called for 80% of National Cancer Control Plans (NCCP) to include radiotherapy by 2020. As part of the ongoing ESTRO Global Impact of Radiotherapy in Oncology (GIRO) project, we assessed whether inclusion of radiother-apy in NCCPs correlates with radiotherapy machine availability, national income, and geographic region.Methods: A previously validated checklist ...

Modern radiotherapy techniques versus three-dimensional conformal radiotherapy for head and neck cancer KU Leuven

Julie Van Der Veen, Annouschka Laenen, Sandra Nuyts

© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of modern radiotherapy techniques (IMRT, VMAT, proton beam therapy and adaptive radiotherapy) compared to 3DCRT on disease control and toxicity in head and neck cancer patients.

Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy Universiteit Gent

Charles Van Praet, Piet Ost, Nicolaas Lumen, Gert De Meerleer, Katrien Vandecasteele, Geert Villeirs, Karel Decaestecker, Valérie Fonteyne

Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study Universiteit Gent

Piet Ost, Bruno Speleers, Gert De Meerleer, Wilfried De Neve, Valérie Fonteyne, Geert Villeirs, Werner De Gersem

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc) : a multicentre, phase 2-3, randomised, controlled trial Universiteit Gent

Sylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, Sebastien Carrere, Anne Ducassou, Marie-Pierre Sunyach, Peter Agoston, Angela Hong, Augustin Mervoyer, Marco Rastrelli, et al.

Exploring all avenues for radiotherapy in oligorecurrent prostate cancer disease limited to lymph nodes : a systematic review of the role of stereotactic body radiotherapy Universiteit Gent

Elisabetta Ponti, Andrea Lancia, Piet Ost, Fabio Trippa, Luca Triggiani, Beatrice Detti, Gianluca Ingrosso

Immunotherapy and Modern Radiotherapy Technique for Older Patients with Locally Advanced Head and Neck Cancer: A Proposed Paradigm by the International Geriatric Radiotherapy Group Vrije Universiteit Brussel

Nam P Nguyen, Lyndon Kim, Juliette Thariat, Brigitta G Baumert, Thandeka Mazibuko, Olena Gorobets, Vincent Vinh - Hung

The standard of care for locally advanced head and neck cancer is concurrent chemoradiation or postoperative irradiation with or without chemotherapy. Surgery may not be an option for older patients (70 years old or above) due to multiple co-morbidities and frailty. Additionally, the standard chemotherapy of cisplatin may not be ideal for those patients due to oto- and nephrotoxicity. Though carboplatin is a reasonable alternative for ...

Publicaties